Effects of chronic haloperidol and sulpiride treatment on rat nigral GABA content. 1981

L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli

The effects of chronic haloperidol and sulpiride treatment on nigral GABA content were investigated in rats. Chronic sulpiride treatment is capable of inducing an increase in nigral GABA content whilst no significant effect is observed following chronic haloperidol treatment at the doses used. The different effects of haloperidol and sulpiride on nigral GABA content were related to the different neuropharmacological spectrum of the two drugs.

UI MeSH Term Description Entries
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
January 1980, Advances in biochemical psychopharmacology,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
October 1978, Life sciences,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
February 1980, Life sciences,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
August 1983, Pharmacology, biochemistry, and behavior,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
October 1986, European journal of pharmacology,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
May 1994, Synapse (New York, N.Y.),
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
January 1988, Psychopharmacology,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
January 1983, Folia psychiatrica et neurologica japonica,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
January 1976, Arzneimittel-Forschung,
L Rampello, and G Giammona, and F Patti, and A Reggio, and F Nicoletti, and R M Di Giorgio, and D F Condorelli
May 1989, Neurochemical research,
Copied contents to your clipboard!